Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1504-1510

  Taner, T ^a   Gandhi, M J ^b   Sanderson, S O ^b   Poterucha, C R ^b   De Goey, S R ^b   Stegall, M D ^a   Heimbach, J K ^a  

^a Division of Transplant Surgery   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Complement C4d; donor specific antibodies; HLA antibodies; liver transplantation

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ADULT; AGED; ALLOGRAFT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CENTRAL VEIN; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROMA CELL; SUBENDOTHELIUM;

AUTOANTIBODIES; HLA ANTIGENS; HUMANS; LIVER TRANSPLANTATION; PREVALENCE; TREATMENT OUTCOME;

EID: 84861800894     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.03995.x     Document Type: Article

References (28)

1. Gloor J, Cosio F, Lager DJ, Stegall MD,. The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008; 8: 1367-1373.
2. Terasaki PI, Cai J,. Human leukocyte antigen antibodies and chronic rejection: From association to causation. Transplantation 2008; 86: 377-383.
3. Kfoury AG, Renlund DG, Snow GL, et al,. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant 2009; 28: 51-57.
4. Demetris AJ, Murase N, Nakamura K, et al,. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992; 12: 51-59.
5. Doyle HR, Marino IR, Morelli F, et al,. Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996; 224: 168-177.
6. Gordon RD, Fung JJ, Markus B, et al,. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705-715.
7. Hathaway M, Gunson BK, Keogh AC, Briggs D, McMaster P, Neuberger JM,. A positive crossmatch in liver transplantation: No effect or inappropriate analysis? A prospective study. Transplantation 1997; 64: 54-59.
8. Neumann UP, Lang M, Moldenhauer A, et al,. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001; 71: 1163-1168.
9. Castillo-Rama M, Castro MJ, Bernardo I, et al,. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility. Liver Transpl 2008; 14: 554-562.
10. Kozlowski T, Rubinas T, Nickeleit V, et al,. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl 2011; 17: 357-368.
11. Muro M, Marin L, Miras M, et al,. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: Experience of one centre. Transpl Immunol 2005; 14: 91-97.
12. O'Leary JG, Kaneku H, Susskind BM, et al,. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant. Am J Transplant 2011; 14: 1600-6143.
13. Gloor JM, DeGoey S, Ploeger N, et al,. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004; 78: 221-227.
14. Musat AI, Agni RM, Wai PY, et al,. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11: 500-510.
15. Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M,. Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int 2010; 23: 858-859.
16. McMillan RW, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, McDonald JC,. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin Transplant 1997; 11: 98-103.
17. Starzl TE, Valdivia LA, Murase N, et al,. The biological basis of and strategies for clinical xenotransplantation. Immunol Rev 1994; 141: 213-244.
18. Colvin RB,. C4d in liver allografts: A sign of antibody-mediated rejection? Am J Transplant 2006; 6: 447-448.
19. Olausson M, Mjornstedt L, Norden G, et al,. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007; 7: 130-136.
20. Dar W, Agarwal A, Watkins C, et al,. Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. Am J Transplant 2011; 11: 841-847.
21. Haas M, Rahman MH, Racusen LC, et al,. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006; 6: 1829-1840.
22. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU,. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007; 7: 1808-1814.
23. Sakashita H, Haga H, Ashihara E, et al,. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007; 20: 676-684.
24. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S,. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005; 19: 110-114.
25. Watson R, Kozlowski T, Nickeleit V, Woosley JT, Schmitz JL, Zacks SL, et al,. Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant 2006; 6: 3022-3029.
26. Schmeding M, Dankof A, Krenn V, et al,. C4d in acute rejection after liver transplantation: A valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006; 6: 523-530.
27. Worthington JE, McEwen A, McWilliam LJ, Picton ML, Martin S,. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 2007; 83: 398-403.
28. Burns JM, Cornell LD, Perry DK, et al,. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684-2694.